Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
NEW YORK and LAVAL, Quebec, Feb. 08, 2016 -- Colgate-Palmolive Company ("Colgate") and Klox Technologies Inc. ("KLOX") have entered into agreements to globally commercialize and further develop KLOX’s human Oral Health technology platform. The agreements include a worldwide license to commercialize KLOX’s proprietary Biophotonic technology in the field of human Oral Health and an equity investment in KLOX by Colgate.
Dr. Lise Hébert, President and CEO of KLOX, stated: "We are extremely pleased to have Colgate-Palmolive, the leader in Oral Care, with activities in over 200 countries and territories be our global partner for our Oral Health platform. These agreements once again recognize the breadth of our technology platform. Furthermore, these agreements validate the value creation strategy we have adopted by partnering large potential indications with first in class partners, while building a specialized salesforce for products within Wound Care."
Suzan Harrison, President of Global Oral Care of Colgate, stated: "We are very pleased to have KLOX as a partner in the development of this exciting and new technology platform for the benefit of Oral Health."
|
|||
About Colgate-Palmolive Company:
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's Ideal Balance. For more information about Colgate's global business, visit the Company's web site at http://www.colgatepalmolive.com. To learn more about Colgate Bright Smiles, Bright Futures® oral health education program, please visit http://www.colgatebsbf.com.
About Klox Technologies Inc.:
KLOX is a specialty pharmaceutical company focused on developing and commercializing products based on its proprietary Biophotonic technology platform to address skin and soft tissue disorders. The company has a multi-franchise platform focusing on indications across Dermatology, Wound Care, and Oral Health.
To learn more about KLOX, please visit http://www.kloxtechnologies.com.
Colgate-Palmolive Company Media Contact: Mitali Chopra – [email protected] Klox Technologies Inc. Media Contact: Mr. Michael Rice – [email protected]
